Find clinical trials for Breast Cancer in Roma, Lazio
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Roma, Lazio, ITA:
Breast cancer is the most common form of cancer among women. For patients candidated for adjuvant chemotherapy and endocri...
Phase 3
Roma, RM, Italy and 74 other locations
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...
Phase 1, Phase 2
Rome, Italy and 71 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Rome, Lazio, Italy and 319 other locations
look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...
Phase 3
Roma, Italy and 144 other locations
medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...
Phase 1, Phase 2
Rome, Lazio, Italy and 37 other locations
with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...
Phase 3
Roma, Italy and 166 other locations
of trastuzumab + Alpelisib +/- fulvestrant versus trastuzumab + chemotherapy in patients with PIK3CA mutated previously treated HER2+ Advanced Breast...
Phase 3
Roma, Italy and 105 other locations
(SC, PHESGO) following trastuzumab deruxtecan (T-DXd) as induction treatment for HER2-positive unresectable locally recurrent or metastatic breast...
Phase 2
Roma, Italy and 35 other locations
This study will evaluate mechanisms of resistance to anti-breast cancer therapies in tumor and blood samples from participants with ...
Phase 4
Rome, Lazio, Italy and 27 other locations
A study to assess the efficacy and safety of Dato-DXd in the pre-chemotherapy setting for patients with metastatic HR-positive, HER2 IHC 0 breast...
Phase 3
Roma, Italy and 39 other locations
Clinical trials
Research sites
Resources
Legal